Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
Titel:
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
Auteur:
Emkey, Ronald Delmas, Pierre D. Bolognese, Michael Borges, Joao Lindolfo C. Cosman, Felicia Ragi-Eis, Sergio Recknor, Christopher Zerbini, Cristiano A. Neate, Colin Sedarati, Farhad Epstein, Solomon